The main purpose of this legislation is to ensure that health insurance plans provide coverage for medications used to treat autoimmune diseases and specific blood disorders. It aims to improve access to necessary treatments by reducing barriers such as prior authorization requirements. Key provisions of the legislation include a mandate for group health plans and health insurance issuers to cover any drug that is classified as an autoimmune or blood disorder medication.